// App-Quantinova.ai

3556 : CXCR4 controls BCL-2 expression and function by regulating miR-15a/16-1 expression in tumor cells

Researchers

Presenter

  • Shiri Klein Silberman

Principal Investigators

  • Michal Abraham

  • Baruch Bulvik

  • Hanna Wald

  • Orly Eizenberg

  • Dvorah Olam

  • Lola Weiss

  • Katia Beider

  • Ori Wald

  • Shlomo Bulvik

  • Abraham Avigdor

  • Ohad Benjamini

  • Eithan Galun

  • Arnon Nagler

  • Yaron Pereg

  • Amnon Peled

Medical Centers

  • Hebrew University of Jerusalem, Jerusalem, Israel

  • Biokine Therapeutics Ltd, Rehovot, Israel

  • Chaim Sheba Medical Center-Tel Aviv University, Tel-Hashomer, Israel

  • Laniado Hospital, Netanya, Israel

  • BioLineRX LTD, Tel Aviv, Israel.

Locations

  • Israel

Companies

  • Biokine LTD

  • BioLineRx Ltd.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Stromal cell-derived factor 1

Drug/Treatment

  • BL-8040

  • CXCL12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved